Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors

NCT00039494 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

171

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma

Interventions

DRUG: erlotinib hydrochloride
RADIATION: 3-dimensional conformal radiation therapy
DRUG: temozolomide

Sponsor

National Cancer Institute (NCI)